$3.01 Million

Estimate Recalculated Nov 1, 2024 11:41AM EST

Who is Dean yLi

Dean yLi has an estimated net worth of $3.01 Million. This is based on reported shares across multiple companies, which include Merck & Co., Inc., and RECURSION PHARMACEUTICALS, INC..

SEC CIK

Dean yLi's CIK is 0001837016

Past Insider Trading and Trends

2021 was Dean yLi's most active year for acquiring shares with 12 total transactions. Dean yLi's most active month to acquire stocks was the month of March. 2021 was Dean yLi's most active year for disposing of shares, totalling 11 transactions. Dean yLi's most active month to dispose stocks was the month of April. 2024 saw Dean yLi paying a total of $3,989,069.94 for 149,439 shares, this is the most they've acquired in one year. In 2024 Dean yLi cashed out on 29,404 shares for a total of $1,845,083.36, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Merck & Co., Inc.

Executive VP & President, MRL
Updated May 02, 2024
Form 4
65.63K
May 02, 2024
112.03K
Grant
Apr 30
Form 4
-24.12%
-14.70K
$93.79
-$932.53K
Feb 12, 2024
46.24K
Sale
Feb 09
Form 4
125.77%
25.76K
$119.43
$3.08M
Jan 24, 2024
46.24K
Grant
Jan 22
Form 4
77.45K
May 04, 2023
97.93K
Grant
May 02
Form 4
-2.50%
-524.00
$115.47
$62.12K
May 03, 2023
20.47K
Options
May 01
Form 4
19.66%
3.27K
$109.88
$359.86K
Jan 25, 2023
19.93K
Grant
Jan 23
Form 4
75.73K
May 05, 2022
92.19K
Grant
May 03
Form 4
-2.26%
-381.00
$87.65
$34.36K
May 04, 2022
16.46K
Options
May 03
Form 4
-2.96%
-523.00
$88.69
$47.72K
May 03, 2022
17.13K
Options
May 01
Form 4
24.30%
3.02K
$73.51
$222.22K
Feb 28, 2022
15.46K
Grant
Feb 24
Form 4
729.99%
91.60K
$75.98
$34.65K
May 06, 2021
104.15K
Options
May 04
Form 4
-4.00%
-611.00
$74.50
$87.09K
May 04, 2021
14.66K
Options
May 01 - May 03
Form 4
48.60%
3.48K
$72.62
$253.08K
Mar 02, 2021
10.66K
Grant
Feb 26
Form 3
Jan 07, 2021
7.17K
Showing 14 results

RECURSION PHARMACEUTICALS, INC.

Investor
Updated Jul 03, 2024
Form 4
2.21%
1.59K
Jul 03, 2024
3.19M
Grant
Jul 01
Form 4
66.49%
39.29K
Jun 05, 2024
3.21M
Grant
Jun 03
Form 4
2.19%
1.27K
Apr 03, 2024
3.17M
Grant
Apr 01
Form 4
-6.44%
-29.00K
$13.66
-$396.21K
Jan 11, 2024
3.17M
Sale
ScheduledJan 09
Form 4
0.09%
1.20K
Jan 04, 2024
3.20M
Grant
Jan 02
Form 4
-32.06%
-626.05K
Oct 04, 2023
3.20M
Grant
Apr 21 - Oct 02
Form 4
0.25%
1.61K
Jul 06, 2023
3.82M
Grant
Jul 03
Form 4
6.07%
37.84K
Jun 21, 2023
3.91M
Grant
Jun 16
Form 4
0.28%
1.72K
Apr 05, 2023
3.81M
Grant
Apr 03
Form 4
0.25%
1.57K
Jan 05, 2023
3.81M
Grant
Jan 03
Form 4
0.18%
1.09K
Oct 05, 2022
3.81M
Grant
Oct 03
Form 4
0.23%
1.41K
Jul 06, 2022
5.12M
Grant
Jul 01
Form 4
9.08%
54.44K
Jun 16, 2022
5.18M
Grant
Jun 14
Form 4
0.26%
1.54K
Apr 05, 2022
5.10M
Grant
Apr 01
Form 4
0.11%
659.00
Jan 05, 2022
5.10M
Grant
Jan 03
Form 4
-1.19%
-15.90K
$20.48
-$325.63K
Dec 09, 2021
3.78M
Sale
ScheduledDec 07
Form 4/A
-1.41%
-19.10K
$20.16
-$384.96K
Dec 09, 2021
1.93M
Sale
ScheduledNov 17 - Nov 19
Form 4
-3.20%
-19.10K
$20.16
-$384.96K
Nov 19, 2021
3.80M
Sale
ScheduledNov 17 - Nov 19
Form 4
0.09%
543.00
Oct 05, 2021
3.82M
Grant
Oct 01
Form 4
0.06%
330.00
Jul 06, 2021
3.82M
Grant
Jul 01
Form 4
Apr 22, 2021
3.85M
Options
Apr 20
Form 4
7.15%
41.67K
Apr 19, 2021
3.85M
Grant
Apr 15 - Apr 16
Form 3
Apr 15, 2021
3.75M
Showing 23 results